Combination of ex vivo sentinel lymph node mapping and methylene blue-assisted lymph node dissection in gastric cancer: A prospective and randomized study

Annals of Surgical Oncology

Volumn 18, Issue 7, 2011, Pages 1860-1868

  Märkl, Bruno ^a   Moldovan, Alexandra I ^a   Jähnig, Hendrik ^a   Cacchi, Claudio ^a   Spatz, Hanno ^a   Anthuber, Matthias ^a   Oruzio, Daniel V ^a   Kretsinger, Hallie ^a   Arnholdt, Hans M ^a  

^a KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INK; METHYLENE BLUE;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EX VIVO SENTINEL LYMPH NODE MAPPING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MALE; METHYLENE BLUE ASSISTED LYMPH NODE DISSECTION; PARTIAL GASTRECTOMY; PREOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TUMOR CELL;

EID: 85027919912     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1713-4     Document Type: Review

References (32)

1. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg. 1998;228:449-61. (Pubitemid 30194389)
2. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439-49.
3. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453-62.
4. Wang Z, Chen JQ, Cao YF. Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer. World J Gastroenterol. 2010;16:1138-49.
5. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. West Sussex: Wiley; 2010.
6. Ichikura T, Ogawa T, Chochi K, Kawabata T, Sugasawa H, Mochizuki H. Minimum number of lymph nodes that should be examined for the International Union against Cancer/American Joint Committee on cancer TNM classification of gastric carcinoma. World J Surg. 2003;27:330-3.
7. Bunt AM, Hermans J, van de Velde CJ, Sasako M, Hoefsloot FA, Fleuren G, Bruijn JA. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol. 1996;14:2289-94. (Pubitemid 26264880)
8. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M. Radio-guided sentinel node detection for gastric cancer. Br J Surg. 2002;89:604-8. (Pubitemid 34415611)
9. Otani Y, Furukawa T, Kitagawa Y, et al. New method of laparoscopy- assisted function-preserving surgery for early gastric cancer: vagus-sparing segmental gastrectomy under sentinel node navigation. J Am Coll Surg. 2004;198:1026-31. (Pubitemid 38759855)
10. Märkl B, Arnholdt HM, Jähnig H, Spatz H, Anthuber M, Oruzio DV, Kerwel TG. A new concept for the role of ex vivo sentinel lymph nodes in node-negative colorectal cancer. Ann Surg Oncol. 2010;17:2647-55.
11. Märkl B, Wünsch K, Hebick KU, Anthuber M, Probst A, Arnholdt HM, Spatz H. Methylene blue-assisted lymph node dissection in combination with ex vivo sentinel lymph node mapping in gastric cancer. Histopathology. 2009;54:433-41.
12. Kerwel TG, Spatz J, Anthuber M, Wunsch K, Arnholdt H, Markl B. Injecting methylene blue into the inferior mesenteric artery assures an adequate lymph node harvest and eliminates pathologist variability in nodal staging for rectal cancer. Dis Colon Rectum. 2009;52:935-41.
13. Märkl B, Kerwel TG, Jähnig HG, et al. Methylene blue-assisted lymph node dissection in colon specimens: a prospective, randomized study. Am J Clin Pathol. 2008;130:913-9.
14. Mekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID. Lymph node retrieval in rectal cancer is dependent on many factors: the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009;33:1547-53.
15. Neuman H, Carey LA, Ollila DW, et al. Axillary lymph node count is lower after neoadjuvant chemotherapy. Am J Surg. 2006;191:827-9. (Pubitemid 43729388)
16. Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannee G, Bioulac-Sage P, Rullier E. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008;32:45-50.
17. Sobin LH, Wittekind C. TNM classification of malignant tumors. Hoboken: Wiley; 2002.
18. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94:2862-6. (Pubitemid 34547684)
19. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer. 2000;88:921-32. (Pubitemid 30091113)
20. Mullaney PJ, Wadley MS, Hyde C, Wyatt J, Lawrence G, Hallissey MT, Fielding JW. Appraisal of compliance with the UICC/ AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer. Br J Surg. 2002;89:1405-8.
21. Choi HJ, Kim YK, Kim YH, Kim SS, Hong SH. Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma. Ann Surg Oncol. 2002;9:13-9.
22. Deng H, Wu RL, Zhou HY, Huang X, Chen Y, Liu LJ. Significance of Survivin and PTEN expression in full lymph nodeexamined gastric cancer. World J Gastroenterol. 2006;12:1013-7.
23. Luebke T, Baldus SE, Zirbes TK, et al. Lymph node revealing solution in gastric carcinoma does not provide upstaging of the N-status. Oncol Rep. 2005;13:361-5.
24. Basten O, Bandorski D, Bismarck C, Neumann K, Fisseler- Eckhoff A. Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes. Pathologe. 2010;31: 218-24.
25. Okines A, Verheij M, Allum W, Cunningham D, Cervantes A. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v50-4.
26. Bembenek AE, Rosenberg R, Wagler E, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg. 2007;245:858-63. (Pubitemid 46809285)
27. Gretschel S, Bembenek A, Hunerbein M, Dresel S, Schneider W, Schlag PM. Efficacy of different technical procedures for sentinel lymph node biopsy in gastric cancer staging. Ann Surg Oncol. 2007;14:2028-35. (Pubitemid 46988254)
28. Asakuma M, Nomura E, Lee SW, Tanigawa N. Ancillary N.O.T.E.S. procedures for early stage gastric cancer. Surg Oncol. 2009;18:157-61.
29. Cahill RA, Asakuma M, Perretta S, Dallemagne B, Marescaux J. Gastric lymphatic mapping for sentinel node biopsy by natural orifice transluminal endoscopic surgery (notes). Surg Endosc. 2009;23:1110-6.
30. Mochiki E, Kuwano H, Kamiyama Y, et al. Sentinel lymph node mapping with technetium-99m colloidal rhenium sulphide in patients with gastric carcinoma. Am J Surg. 2006;191:465-9. (Pubitemid 43384140)
31. Rabin I, Chikman B, Lavy R, et al. The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer. 2010;13:30-5.
32. Ryu K, Lee J, Kim H, Kim Y, Choi I, Bae J. Prediction of lymph nodes metastasis by sentinel node biopsy in gastric cancer. Eur J Surg Oncol. 2003;29:895-9. (Pubitemid 37493290)